Friday 6 November 2026 Export BDX’s income statement to Excel — free account

Becton, Dickinson and Company

BDX Healthcare Medical Instruments & Supplies

Revenue: −10.5%
EPS: +48.5%
Free cash flow: −31.6%
Total debt: −23.8%

Quarter to September 2026, against a year earlier

212.21 1.34 −0.63%

Follow BDX

Alert me

Market cap: $58.2B
P/E: 51.1×
Fwd P/E: 39.2×
Dividend yield: 1.87%
F-score: 6/9
Altman Z: n/a
Beneish M: −2.76
Dividend safety: 51/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Becton, Dickinson and Company 8-K filed Feb 5, 2026

Period ended Feb 5, 2026 · Filed Feb 5, 2026 · accepted 4:17 PM ET · Document on sec.gov · Filing index

7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits

Nothing in this filing raised a red flag, and we have no summary of it. The items it reports are listed above; the document itself is on sec.gov.

Read the filing on sec.gov